Oryzon
Oryzon is a clinical stage biopharmaceutical company focused on developing personalized medicines based on epigenetics. The company utilizes its epigenetic platform to discover and validate biomarkers and therapeutic targets for advanced treatments. Its pipeline includes candidates like iadademstat and vafidemstat aimed at cancer and CNS disorders.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Oryzon is a clinical stage biopharmaceutical company focused on developing personalized medicines based on epigenetics. The company utilizes its epigenetic platform to discover and validate biomarkers and therapeutic targets for advanced treatments. Its pipeline includes candidates like iadademstat and vafidemstat aimed at cancer and CNS disorders.